Aggrastat

Aggrastat (Tirofiban Hydrochloride Monohydrate) is an intravenous medication used to prevent blood clots. It is commonly prescribed for patients undergoing certain medical procedures to reduce the risk of clot formation.

Aggrastat is primarily used to prevent blood clots in patients undergoing percutaneous coronary intervention (PCI) or those with acute coronary syndrome. It works by inhibiting platelet aggregation, which helps to keep blood flowing smoothly through the arteries. This medication is often used in hospital settings under medical supervision.

Common effects of Aggrastat may include bleeding, bruising, and prolonged bleeding from cuts or injuries. Some patients may also experience nausea, headache, or dizziness. These effects are generally mild and temporary, but any severe or persistent symptoms should be reported to a healthcare professional.

Aggrastat should be handled with care and administered only by healthcare professionals. It is important to inform your doctor about any allergies or medical conditions before starting this medication. Patients with a history of bleeding disorders or recent surgery should use this medication with caution.

Aggrastat may interact with other medications that affect blood clotting, such as anticoagulants or antiplatelet drugs. It is important to discuss all current medications with your healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.